… vibratory therapy for the management of Parkinson's disease. Charcot had observed that
after long carriage, train, or horseback rides, patients with Parkinson's disease experienced …

… In a small cohort of patients with idiopathic RBD (iRBD), the presence of smell impairment
has been detected as a predictive value for conversion to PD and to Parkinson disease with …

… therapy in the form of l-dopa and dopamine agonist drugs is … treatments for other
neurodegenerative diseases. But 40 … dopaminergic therapy and the problems that drug treatment …

… Depression Initiate counseling; consider drug therapy with selective serotonin reuptake
inhibitors or tricyclic antidepressants (because of side effect profile, use tricyclic antidepressants …

… of drug therapy. STN DBS was first reported to have a major impact on the symptoms of
PD by Benabid and his colleagues114, 115 and in the last decade, numerous studies have …

… of dopaminergic drugs can be escalated to treat Parkinsonian … dopaminergic therapy and
therefore worsened Parkinsonian … in patients with early Parkinson's disease who were treated …

… LD remains the gold standard of drug therapy, but the question of when to introduce it in
our 62-year-old patient remains. There are two major conflicting considerations. The patient …

… Here we review clinical trials of disease-modifying therapies in PD that were published
since 2013 as well as ongoing clinical trials. We also discuss promising approaches and …

… symptoms by patients with Parkinson’s disease (PD). Treatment … therapies are currently
available for the treatment of end-of-dose motor fluctuations. Additionally, device-aided therapies…

… Parkinson's disease will increase as the population ages, making it important to identify
reliably the most effective drug therapy … Trials of adjuvant therapy in later Parkinson's disease …